Kathleen Gallagher Weber - 19 Dec 2023 Form 4 Insider Report for ORASURE TECHNOLOGIES INC (OSUR)

Role
Chief Product Officer
Signature
/s/ Michele Anthony, Attorney-In-Fact
Issuer symbol
OSUR
Transactions as of
19 Dec 2023
Net transactions value
-$170,622
Form type
4
Filing time
21 Dec 2023, 16:04:33 UTC
Previous filing
03 Mar 2023
Next filing
09 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OSUR Common Stock Options Exercise $23,597 +4,129 +1.5% $5.71 278,829 19 Dec 2023 Direct F1
transaction OSUR Common Stock Sale $194,219 -24,129 -8.7% $8.05 254,700 19 Dec 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OSUR Non-Qualified Stock Options Options Exercise $0 -4,129 -100% $0.000000* 0 19 Dec 2023 Common Stock 4,129 $5.71 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023.
F2 The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.00 to $8.095, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Non-qualified stock options granted on February 3, 2014, vesting 25% at the end of 12 months after the grant date and 75% ratably on a monthly basis over the next 36 months. Vesting shall cease upon voluntary termination of employment.